Saphnelo 120 mg solution for injection in pre-filled syringe clinical trials

Multinational, Interventional, 52-week, Open-label, Single-arm Study to Evaluate the Treatment Outcomes of Anifrolumab 120 mg Subcutaneous Once Weekly in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus (SUNFLOWER)

This study is testing a new way to treat lupus, called Saphnelo. Doctors want to see if Saphnelo can help people with lupus achieve and stay in remission, meaning their symptoms are well controlled. It's for adults new to certain lupus medicines.